Sichuan University, State Key Laboratory of Biotherapy and Cancer Center, China
Dr. Bo Liu got his PhD degree in Bioinformatics & Biochemistry from School of Life Sciences of Sichuan University in June 2010. Hitherto, he has made some academic achievements for exploring molecular mechanisms of plant lectin-induced cancer cell apoptosis and autophagy. He reported for the first time that Polygonatum cyrtonema lectin (PCL) could simultaneously induce cancer cell apoptosis and autophagy. Based upon the aforementioned findings, he has published 19 scientific peer-review papers as the first author/corresponding author in several known journals such as Autophagy, IJBCB, Cancer Letters,BBA, Biochimie and ABB. Furthermore, as an editorial member, he has co-written three academic books in autophagy field. So far, he has been invited to be a peer reviewer for more than 20 academic journals such as Apoptosis, Cancer Letters, Genomics, ABB, Peptides, Cell proliferation, Process Biochemistry and etc. Now, he is studying PPI-network-based identification of novel apoptotic and autophagic pathways in cancer.
Anti-cancer mechanims of plant lectins in vitro and in vivo; Apoptotic signaling pathways in human cancers; Autophagic signaling pathways in human cancers; Bioinformatics-based anti-cancer drug design.
Metabolomics:Open Access received 691 citations as per Google Scholar report